Dyslipidemia Estimating CV Risk Flashcards

1
Q

How do we asses cardiovascular risk? What is the phrase we use?

A

What is the %PROBABILITY this patient will experience the OUTCOME in the next X YEARS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Differentiate between framingham and ASCVD risk calculators. What do they calculate the risk of? Over/under estimate?

A

Framingham
- risk of heart attack or stroke, heart failure, angina, or intermittent claudication, and mortality
- includes “soft” outcomes which overestimates risk in most population

ASCVD
- calculates: heart attack or stroke (fatal or non-fatal), and mortality
- “HARD” outcomes only (less outcomes) -> leads to a lower risk calculation score overall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What kind of regression analysis do the risk score assessment use?
What kind of estimate is used?
What outcomes it is used for?

A

Multiple linear regression model
- Parameter estimate

Continuous outcome variables (normal distribution), ex.
- Days of hospitalization
- % risk of CVD outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What regression model is used for death?
What kind of estimate is used?
What outcomes it is used for?

A

Logistic regression
- uses Odds ratio
- used for dichotomous outcomes, anything yes or no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What regression model is used for time-to-event (survival data)
What kind of estimate is used?
What outcomes it is used for?

A

Cox regression
- Hazard ratio (proportional hazards regression)
- Used for time to event such as time to first heart attack or how many months before death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 3 phases in multivariable prognostic research?

A
  1. Development studies
    - identifying important predictors and assigning relative weights to them to INTERNALLY validate model
  2. Validation studies
    - EXTERNAL validating the study by assessing predictive performance (discrimination) and improving performance (calibration)
  3. Impact studies
    - Quantifying if the new model truly improves clinical decision and clinical outcomes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are common variables of risk calculators for CV risk factors?

A
  • Age
  • Gender
  • total cholesterol
  • HDL cholesterol
  • systolic BP
  • diabetes
  • current smoking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What key variables are excluded in the following risk scores:
Framingham
QRISK2
ACC/AHA pooled cohort ASCVD risk

A

Framingham
- family history of CVD

QRISK2
- Diabetes

ACC/AHA pooled cohort ASCVD risk
- Family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is framingham risk used for primary or secondary prevention

A

Primary prevention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the guidelines for low, intermediate, & high risk.

A

Low: Under 10%
Intermediate: 10-20%
High: 20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which study did most of our knowledge on CVD risk factors come from?

A

Framingham study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What was the FRS cohort mainly included?

A

White, middle-class American individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which population does the FRSH overestimate? Underestimate?

A

Overestimate:
- Japanese, Hispanic, mediterranean

Underestimate:
- south asians, Indians, Pakistan, Bangladesh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What was NOT included in the FRS

A
  • No socioecomonic status
  • not designed for diabetes
  • No family history (due to recall bias, important)
  • Novel biomarkers: (coronary artery calcification CAC, CRP, BNP, however did not really impact)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Define B-type Natriuretic peptide biomarker

A

A cardiac hormone synthesized in the LV in response to inc ventricular VOLULE or inc pressure in ventricular WALL STRESS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When do we consider biomarkers in risk scores?

A

When they are intermediate-risk
- can make them be pushed to high risk

17
Q

ACC/AHA inclusion criteria

A
  • Caucasian and African American patients
  • Diabetes as a yes/no (not severity)
18
Q

What was not included in the ACC/AHA criteria

A
  • Family history of premature CVD
    (Dad <55 and Mom <65)
19
Q

Does ACC/AHA study over/under estimate? By how much

A

50% overestimation

20
Q

End points of ACC/AHA study? What are they looking for?

A

Fatal + non-fatal MI
Stroke
CHD death

21
Q

What does the SCORE study look at?

A

The vascular age compared to your actual age

22
Q

How often should you use the risk score on patients? What age group?

A

Every 5 years for patients aged 40-75

23
Q

What is the approach to risk score (5 steps)

A
  1. Determine if patient has 1 or more CVD risk factors (HTN, smoking, DM, premature family history, CKD, obesity)
  2. Obtain lipid panel for 20+ age
  3. For primary prevention 40-79yo, use FRS FIRST
    - for patients 20-39 input age as 40
  4. Do 30 years or lifetime if risk is low
  5. Do ASCVD or SCORE
  6. Repeat every 5 years or when a major change happens
  7. Convey results to clinicians and patients (include overestimation)